The effects of ritonavir and lopinavir/ritonavir on the pharmacokinetics of a novel CCR5 antagonist, aplaviroc, in healthy subjects

AIMS: This study assessed the effects of the CYP3A inhibitors lopinavir/ritonavir (LPV/r) on the steady-state pharmacokinetics (PK) of aplaviroc (APL), a CYP3A4 substrate, in healthy subjects. METHODS: In Part 1, APL PK was determined in eight subjects who received a single oral 50-mg APL test dose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Adkison, Kimberly K, Shachoy-Clark, Anne, Fang, Lei, Lou, Yu, Otto, Vicky R, Berrey, M Michelle, Piscitelli, Stephen C
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2006
Schlagworte:
Drug Interactions
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885134/
https://ncbi.nlm.nih.gov/pubmed/16934050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02661.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge